Header

Responsibility

As a global leader in pain management, conducting business responsibly is a core part of our company’s strategy and culture. We provide transparent responsibility and sustainability reporting on our progress, and our performance is regularly rated by an independent agency according to environmental, social and governance (ESG) criteria. We join forces for sustainability and are committed to supporting the United Nations Sustainable Development Goals (SDGs).

Gabriel Baertschi CEO Grünenthal

“Striving for a world free of pain is our vision at Grünenthal. We place a strong focus on our responsibility to contribute to a sustainable future for all.”

Gabriel Baertschi

CEO

Recent corporate responsibility activities

Corporate responsibility – 2022 in numbers

100%

completion rate for training about our Code of Conduct, conflicts of interest and corporate responsibility by March 2023.

2%

Grünenthal’s ESG risk rating for 2023 is in the top 2% of the pharmaceuticals sub-industry.

34%

female share of employees in executive roles (2022 vs. 19% in 2018).

€4.4m

invested worldwide in awareness and accessibility initiatives in 2022.

600k

visitors to our educational websites for pain management in 2022.

-32%

reduction in Scope 2 emissions (indirect CO2e emissions from acquired energy) in 2022.

Grünenthal Responsibility Report

Responsibility Report 2022/2023

Our Responsibility Report shares insights into how we conduct our business responsibly, as well as details about our impact on society and the environment. The report offers updates on the goals and KPIs that measure our progress along the value chain. We report in line with the Global Reporting Initiative (GRI) standards and subject our reporting to external auditing.
... Responsibility Report 2022/2023 PDF
UN Sustainable Development Goals

UN Sustainable Development Goals (SDGs)

We are committed to supporting the SDGs in line with our business strategy. As a leading pharmaceutical company, we can make strong contributions to SDG 3 (Good Health and Well-being), SDG 8 (Decent Work and Economic Growth), SDG 9 (Industry, Innovation and Infrastructure), SDG 12 (Responsible Consumption and Production) and SDG 13 (Climate Action).
... UN SDGs
Sustainalytics rating agency logo

ESG risk rating – Grünenthal ahead of peers

Our performance in environmental, social and governance (ESG) criteria is evaluated by an external rating from Sustainalytics. In 2023, we were attributed a low ESG risk. This places Grünenthal in the top two percent of the global pharmaceuticals subindustry, which inherently features higher ESG risk.
... Sustainalytics rating
Ecovadis 2022 Sustainability Rating

Silver medal for sustainability

EcoVadis is the world's largest and most trusted provider of business sustainability ratings. Our Silver Medal rating puts Grünenthal in the top 25 percent of companies assessed worldwide. The rating evaluates companies across four key areas: Environment, labour and human rights, ethics, and sustainable procurement.
... Ecovadis rating